請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9270
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山 | |
dc.contributor.author | Chung-Fan Wei | en |
dc.contributor.author | 魏中帆 | zh_TW |
dc.date.accessioned | 2021-05-20T20:15:22Z | - |
dc.date.available | 2014-09-15 | |
dc.date.available | 2021-05-20T20:15:22Z | - |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-14 | |
dc.identifier.citation | 行政院衛生署食品衛生處。2002。健康食品之免疫調節評估方法
Ara Y, Saito T, Takagi T, Hagiwara E, Miyagi Y, Sugiyama M, Kawamoto S, Ishii N, Yoshida T, Hanashi D, Koshino T, Okada H, Okuda K. (2001) Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology. 103(1):98-105 Asahi-Ozaki Y, Yoshikawa T, Iwakura Y, Suzuki Y, Tamura S, Kurata T, Sata T. (2004) Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J Med Virol. 74(2):328-335 Bender BS, Johnson MP, Small PA. (1991) Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 72(4):514-519 Benyacoub J, Rochat F, Saudan KY, Rochat I, Antille N, Cherbut C, von der Weid T, Schiffrin EJ, Blum S. (2008) Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J Nutr.138(1):123-9 Bilsborough J, Viney JL. (2004) Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127(1):300-309 Brandtzaeg P, Carlsen HS. Halstensen TS. (2006) The B-cell system in inflammatory bowel disease. Adv Exp Med Biol. 579:149-167 Butcher EC, Rouse RV, Coffman RL, Nottenburg CN, Hardy RR, Weissman IL. (1982) Surface phenotype of Peyer’s patch germinal center cells: implications for the role of germinal centers in B cell differentiation . J Immunol. 129(6):2698-2707 Chang HH, Chen CS, Lin JY. (2009) Dietary perilla oil lowers serum lipids and ovalbumin-specific IgG1, but increases total IgE levels in ovalbumin-challenged mice. Food Chem Toxicol. 47(4):848-54 Cheung NK, Modak S, Vickers A, Knuckles B. (2002) Orally administered b-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother. 51(10): 557-64 Clements JD, Hartzog NM, Lyon FL. (1988) Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein anitgens. Vaccine. 6(3):269-77 Corthesy B. (2007) Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol. 178(1):27-32 Dalmo RA, Bøgwald J. (2008) Beta-glucans as conductors of immune symphonies. Fish Shellfish Immunol. 25(4):384-96 DeKruyff RH, Rizzo LV, Umetsu DT. (1993) Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol. 5(6):421-30 Dennehy PH. (2008) Rotavirus Vaccines: an overview. Clin microbiol Rev. 21(1):198-208 Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, Gordon S, Reis LF, Dias AA, (2004) PTX3 function Medicinal applications of fungal glucans as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol. 75(4):649-656 Du Z, Kelly E, Mecklenbrauker I, Agle L, Herrero C, Paik P, Ivashkiv LB. (2006) Selective regulation of IL-10 signaling and function by zymosan. J Immunol. 176(8): 4785-92 Elson CO, Ealding W. (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol. 133(6):2892–7 Gallatin WM, Weissman IL, Butcher EC. (2006) A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 304(5921):30-4 Glezen WP. (1982) Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 4:25-44 de Haan L, Verweij WR, Feil IK, Lijnema TH, Hol WG, Agsteribbe E, Wilschut J. (1996) Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect Immun. 64(12):5413-6. Heritage PL, Brook MA, Underdown BJ, McDermott MR. (1998) Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes. Immunology. 93(2):249-256. Heritage PL, Underdown BJ, Arsenault AL, Snider DP, McDermott MR. (1997) Comparison of murine nasal-associated lymphoid tissue and Peyer’s patches. Am J Respir Crit Care Med. 156(4 Pt 1):1256-1262. Hishiki H, Zuercher AW, Valosky J, Coffin SE. (2004) Regional differences in the early mucosal immune response induced by primary inoculation of mice with respiratory syncytial virus. Microb Pathog. 36(3):141-146 Holmgren J, Czerkinsky C. (2005) Mucosal immunity and vaccine. Nat Med Rev. 11:s45-s53 Hornquist CE, Ekman L, Grdic KD, Schon K, Lycke NY. (1995) Paradoxical IgA immunity in CD4-defient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J Immunol. 155(6):2877-2887 Humen MA, De Antoni GL, Benyacoub J, Costas ME, Cardozo MI, Kozubsky L, Saudan KY, Boenzli-Bruand A, Blum S, et al. (2005) Lactobacillus Johnsonii La1 antogonizes Giardia intestinalis in vivo. Infect Immun. 73(2):1265-9 Iwasaki A, Kelsall BL. (1999) Freshly isolated Peyer’s patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med. 190(2):229-239 Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity. 21(4):527-538 Janeway CA, Travers P, Walport M, Shlomchik MJ. (2005) Immunobiology, 6th edn. (Garland Science, New York and London) Jelinek T, Kollaritsch H. (2008) Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev Vaccines. 7(5):561-7 Kiyono H, Fukuyama S. (2004) NALT-versus Peyer’s-patch-mediated mucosal immunity Nat Rev. Immunol. 4(9):699-710 Kweon MN, Yamamoto M, Watanabe F, Tamura S, Van Ginkel FW, Miyauchi A, Takagi H, Takeda Y, Hamabata T, Fujihashi K, McGhee JR, Kiyono H. (2002) A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis. 186(9):1261-9 Latiff AH, Kerr MA. (2007) The clinical significance of immunoglobulin A deficiency . Ann Clin Biochem. 44(Pt 2):131-139 Lee MS, Yang CF. (2003) Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. J Infect Dis. 188(9):1362-6 Lycke N, Erlandsson L, Ekman L, Schon K, Leanderson T. (1999) Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol. 163(2):913-919 Lycke N, Eriksen L. Holmgren J. (1987) Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin. Scand J Immunol. 25(4):413-419 Lycke N, Holmgren J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 59(2):301-8 Ma DW, Seo J, Switzer KC, Fan YY, McMurray DN, Lupton JR, Chapkin RS. (2004) N-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem. 15(11):700-706 Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. (2000) A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288(5474):2222-2226 Macpherson AJ, Hunziker L, McCoy K, Lamarre A. (2001) IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect. 3(12):1021-35 Macpherson AJ, Uhr T. (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 303(5664):1662-1665 Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, et al. (2004) Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J. 23(11):1053-5 Mestecky J. et al. (2005) Mucosal Immunolgy 3rd edn. (Academic Press, San Diego) Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, Otipoby KL, Yokota A, Takeuchi H, Ricciardi-Castagnoli P, Rajewsky K, Adams DH, von Andrian UH. (2006) Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 314(5802):1157–1160 Momoi F, Hashizume T, Kurita-Ochiai T, Yuki Y, Kiyono H, Yamamoto M. (2008) Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect Immun. 76(6):2777-84 Mowat AM. (2003) Anatomical basis of tolerance and immunity to immunity to intestinal antigen. Nat Rev Immunol. 3(4):331-341 Mushiake H, Tsunoda T, Nukatsuka M, Shimao K, Fukushima M, Tahara H. (2005) Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo. Cancer Immunol Immunother. 54(2):120-8 Nagafuchi S, Totsuka M, Hachimura S, Goto M, Takahashi T, Yajima T, Kuwata T, Kaminogawa S. (2002) Dietary nucleotides increase the mucosal IgA response and the secretion of transforming growth factor beta from intestinal epithelial cells in mice. Cytotechnology. 40(1-3):49-58 Nikolic T, Dingjan GM, Leenen PJ, Hendriks RW. (2002) A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur J Immunol. 32(2):686–92 Nicolosi R, Bell SJ, Bistrian BR, Greenberg I, Forse RA, Blackburn GL. (1999) Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr. 70(2):208-12 Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. (2001) MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 49(4):526-33 Otten M.A, van Egmond, M. (2004) The Fc receptor for IgA (FcaRI, CD89). Immunol Lett. 92(1-2):23-31 Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. (2004) Recognition of commensal microflora by toll-like receptors s required for intestinal homeostasis. Cell. 118(2):229-241 Renegar KB, Small PA Jr. (1991) Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol. 65(4):2146-8 Rodríguez-Monroy MA, Rojas-Hernández S, Moreno-Fierros L. (2007) Phenotypic and functional differences between lymphocytes from NALT and nasal passages of mice. Scand J Immunol. 65(3):276-88 Sait LC, Galic M, Price JD, Simpfendorfer KR, Diavatopoulos DA, Uren TK, Janssen PH, Wijburg OL, Strugnell RA. (2007) Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora. Int Immunol. 19(3):257-265 Saito K, Yajima T, Nishimura H, Aiba K, Ishimitsu R, Matsuguchi T, Fushimi T, Ohshima Y, Tsukamoto Y, Yoshikai Y. (2003) Soluble branched beta-(1,4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response with immunoglobulin E production in vivo. J Biol Chem. 278(40):38571-8 Salvi S, Holgate ST. (1999) Could the airway epithelium play an important role in mucosal immunoglobulin A production? Clin Exp Allergy. 29(12):1597-605 Sanderson IR. (2007) Dietary modulation of GALT. J Nutr. 137(11 Suppl):2557S-2562S Schijns VE. (2003) Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine. 21(9-10):829-31 Shimoda M, Nakamura T, Takahashi Y, Asanuma H, Tamura S, Kurata T, Mizuochi T, Azuma N, Kanno C, Takemori T. (2001) Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue. J Exp Med.194(11):1597-1607 Sijben JW, Calder PC, (2007) Differential immunomodulation with longchain n-3 PUFA in health and chronic disease. Proc Nutr Soc. 66(2):237-259 Snider DP, Marshall JS, Perdue MH, Liang H. (1994) Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol. 153(2):647-57 Steinman RM, Hawiger D, Nussenzweig MC. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685–711 Streeter PR, RouseBT, Butcher EC. (1988) Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol. 107(5):1853-1862 Tamura S, Shoji Y, Hashigucci K, Aizawa C, Kurata T. (1994) Effect of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine. 12(13):1238-40 Tsuji T, Yokochi T, Kamiya H, Kawamoto Y, Miyama A, Asano Y. (1997) Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action. Immunology. 90(2):176-82 Tumpey TM, Renshaw M, Clements JD, Katz JM. (2001) Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol. 75(11):5141-50 Uauy R, Stringel G, Thomas R, Quan R. (1990) Effect of dietary nucleosides on growth and maturation of the developing gut in the rat. J Pediatr Gastroenterol Nutr. 10(4):497-503. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, Kiyono H, Miyasaka M, Ishii KJ, Akira S. (2008) Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol. 9(7):769-76 Volman JJ, Ramakers JD, Plat J. (2008) Dietary modulation of immune function by beta-glucans. Physiol Behav. 94(2):276-84 Vrese M, Schrezenmeir J. Probiotics, Prebiotics, and Synbiotics. (2008) Adv Biochem Engin/Biotechnol. 111: 1–66 Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. (2000) The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer’s patch high endothelial venules . J Exp Med. 191(1):77-88 Watanabe S, Sakai N, Yasui Y, Kimura Y, Kobayashi T, Mizutani T, Okuyama H. (1994) A high a-linolenate diet suppresses antigen-induced immunoglobulin E response and anaphylactic shock in mice. J Nutr. 124(9):1566-73 Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. (2006) Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med. 203(1):21-26 Youngman KR, Franco MA, Kuklin NA, Rott LS, Butcher EC, Greenberg HB. (2002) Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen specific B cells during the murine anti-rotavirus immune response. J Immunol. 168(5):2173-2181 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9270 | - |
dc.description.abstract | 來自靈芝、酵母菌等真菌細胞壁的多醣類,如以β(1→3), β(1→6)鍵結之化合醣類,統稱為β-聚糖。β-聚糖被報導具有免疫調節的能力,如增進免疫力能預防癌症及微生物感染;或是改變免疫反應的途徑,如降低Th2反應卻增加Th1反應,以減少過敏發生。而鼻腔內給予之疫苗能除了引發接種者血清中特異性免疫球蛋白G (Immunoglobulin G, IgG),更能使接種者產生在上呼吸道局部的分泌型免疫球蛋白A,IgA在黏膜能中和外來物抗原,降低經飛沬傳染散播的微生物入侵宿主之機率,這是注射疫苗很難達到的效果。並且鼻腔疫苗有容易施行大規模接種之優點,雖然大部分鼻腔疫苗尚在實驗階段,但其具有研發潛力。實驗建立鼻腔內致免的動物模式。以大腸桿菌致病株所分離的忌熱性腸毒素(heat-labile enterotoxin, LT)做為佐劑,卵清白蛋白(ovalbumin, OVA)為抗原,從鼻腔給予BALB/c小鼠。而小鼠從致免前一周開始每周三次分別餵食二次水、熱致死之啤酒酵母或市售啤酒酵母大豆發酵產物直到犧牲。實驗期間,每週採集小鼠的唾液、測定抗白蛋白之分泌型IgA以及採集血清測定抗OVA之IgG和IgE。結果顯示,小鼠餵食啤酒酵母及市售啤酒酵母大豆發酵產物的小鼠唾液中有較高的抗OVA特異性唾液IgA及血清中IgG和IgE。初步認為飲食中含有啤酒酵母及市售啤酒酵母大豆發酵產物可促進特定免疫球蛋白生成,可能透過Th1之細胞激素IFN-γ和Th2之細胞激素IL-5的分泌增加。因此服用熱致死啤酒酵母的相關產品可能加強宿主保護力,增進鼻腔內疫苗效果,但亦有增加對特定抗原過敏之風險。 | zh_TW |
dc.description.abstract | β-glucans as β(1→3), β(1→6) binding polysaccharides derived from fungal cell wall, like Ganoderma lucidum and yeasts. β-glucans have been reported that confers immunomodulation with oral administration or intravenous injection. The immunomodulated functions of β-glucans may promote lymphocytes tumor cytotoxic ability or protect against microbial infections. Nevertheless, some kinds of β-glucan can also skew Th1/Th2 balance, may inhibit allergic response. Intranasal administrated nasal vaccines elicit hosts’ systemic specific immunoglobulin G (IgG), also elicit scretory IgA that may neutralize respiratory pathogens at local mucosa. Nasal vaccines are potential, since they are easily accessible for large population, and required without needles and syringes. In present research, we nasal immunized BALB/c mice with heat-labile enterotoxin(LT) from wild-type entero-pathogenic E. coli and ovalbumin (OVA) for 4 times, 1-week internal. In parallel, we oral administrated the mice with sterile water, heat-killed sacchromyces cerevisiae, or commercial sacchromyces cerevisiae legume fermentated product trice a week, started from 1 week before the first nasal immunization, and last to the second week after the last immunization, mice were sacrificed. Saliva, serum of mice was collected every week since feeding started, the samples were detected the specific anti-OVA IgA, IgG and IgE with ELISA. The present data shows that anti-OVA salivary IgA and anti-OVA serum IgG1, IgG2a and IgE in sacchromyces cerevisiae and commercial sacchromyces cerevisiae legume fermentated product-feeding mice with LT+OVA immunized. It’s preliminarily considered that sacchromyces cerevisiae or related products-intake may enhance specific antibody production, through IL-5 and IFN-γ-secreting increased. Therefore, oral intake sacchromyces cerevisiae or related products may protect hosts against pathogen, enhance nasal vaccine efficacy, but increase IgE-mediated allergy risk. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T20:15:22Z (GMT). No. of bitstreams: 1 ntu-98-R96450012-1.pdf: 718706 bytes, checksum: ccfa1c76dfd31a9bbbe9c7db27e61a6c (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 中文摘要.........................................................................................................................i
英文摘要.........................................................................................................................ii 圖目錄.............................................................................................................................iii 第一章 文獻回顧...........................................................................................................1 第一節 黏膜免疫.....................................................................................................1 第二節 鼻腔免疫與鼻腔相關淋巴組織免疫.........................................................3 第三節 腸道免疫.....................................................................................................4 第四節 健康食品的免疫調節.................................................................................5 第五節 啤酒酵母.....................................................................................................6 第六節 健康食品之免疫調節評估方法.................................................................8 第七節 研究動機與目的.........................................................................................8 第二章 材料及方法.....................................................................................................10 第一節 實驗動物小鼠...........................................................................................10 第二節 製備熱致死啤酒酵母...............................................................................10 第三節 餵食與黏膜致免計畫...............................................................................10 第四節 檢體與組織收集.......................................................................................11 第五節 酵素連結免疫吸附試驗...........................................................................12 第六節 細胞增生測試...........................................................................................14 第七節 細胞分群測定...........................................................................................14 第八節 聚丙烯醯胺膠體電泳法及銀染...............................................................14 第九節 統計方法...................................................................................................15 第三章 實驗結果.........................................................................................................16 第一節 鼻腔致免溶液進行膠片電泳...................................................................16 第二節 小鼠體重比較...........................................................................................16 第三節 唾液、BALF、血清中抗OVA之特異性IgA.............................................16 第四節 血清中抗OVA之特異性IgG與IgE.........................................................17 第五節 唾液、BALF、血清中總IgA含量..............................................................18 第六節 血清中總IgG和IgE..................................................................................19 第七節 脾臟及不同淋巴結細胞的特異性增生...................................................20 第八節 脾臟及不同淋巴結細胞的非特異性增生...............................................21 第九節 初代細胞針對OVA分泌的細胞激素......................................................22 第十節 初代免疫細胞分群之百分比...................................................................23 第四章 討論.................................................................................................................23 第一節 唾液、BALF、血清中抗OVA之特異性IgA與細胞激素......................23 第二節 血清中抗OVA之特異性IgG與IgE與細胞激素....................................24 第三節 血清中總抗體含量...................................................................................25 第四節 胰臟及淋巴結細胞的增生與細胞表現型之百分比...............................26 第五節 小鼠體重比較...........................................................................................26 第五章 總結論.............................................................................................................27 第六章 參考文獻.........................................................................................................29 | |
dc.language.iso | zh-TW | |
dc.title | 口服酵母菌對BALB/c小鼠鼻腔黏膜免疫之調節能力 | zh_TW |
dc.title | Immunomodulation of saccharomyces cerevisiae on intranasalsal immunization in BALB/c mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李建國,顧家綺,徐悠深 | |
dc.subject.keyword | 免疫調節,鼻腔內致免,唾液免疫球蛋白A,血清免疫球蛋白, | zh_TW |
dc.subject.keyword | immunomudulation,intranasal immunization,salivary IgA,serum immunoglobulins, | en |
dc.relation.page | 46 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2009-07-14 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf | 701.86 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。